BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22683460)

  • 21. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
    Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
    Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatiotemporal dynamics of OCT4 protein localization during preimplantation development in mice.
    Fukuda A; Mitani A; Miyashita T; Kobayashi H; Umezawa A; Akutsu H
    Reproduction; 2016 Nov; 152(5):417-30. PubMed ID: 27495230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency.
    Wei Z; Gao F; Kim S; Yang H; Lyu J; An W; Wang K; Lu W
    Cell Stem Cell; 2013 Jul; 13(1):36-47. PubMed ID: 23747203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The differential expression of OCT4 isoforms in cervical carcinoma.
    Li SW; Wu XL; Dong CL; Xie XY; Wu JF; Zhang X
    PLoS One; 2015; 10(3):e0118033. PubMed ID: 25816351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
    Poursani EM; Mehravar M; Soltani BM; Mowla SJ
    Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
    Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
    Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
    Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
    Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling reveals the heterogeneous transcriptional activity of Oct3/4 and its possible interaction with Gli2 in mouse embryonic stem cells.
    Li Y; Drnevich J; Akraiko T; Band M; Li D; Wang F; Matoba R; Tanaka TS
    Genomics; 2013; 102(5-6):456-67. PubMed ID: 24121003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
    Mehravar M; Poursani EM
    Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential role for transcription factor Oct4 nucleocytoplasmic dynamics in somatic cell reprogramming and self-renewal of embryonic stem cells.
    Oka M; Moriyama T; Asally M; Kawakami K; Yoneda Y
    J Biol Chem; 2013 May; 288(21):15085-97. PubMed ID: 23580657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique Oct4 interface is crucial for reprogramming to pluripotency.
    Esch D; Vahokoski J; Groves MR; Pogenberg V; Cojocaru V; Vom Bruch H; Han D; Drexler HC; Araúzo-Bravo MJ; Ng CK; Jauch R; Wilmanns M; Schöler HR
    Nat Cell Biol; 2013 Mar; 15(3):295-301. PubMed ID: 23376973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostication of OCT4 isoform expression in prostate cancer.
    de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
    Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
    Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
    BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
    Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
    Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
    Saha SK; Jeong Y; Cho S; Cho SG
    Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific expression pattern of a novel Otx2 splicing variant during neural differentiation.
    Liu Z; Chi L; Fang Y; Liu L; Zhang X
    Gene; 2013 Jul; 523(1):33-8. PubMed ID: 23566845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma.
    Karoubi G; Cortes-Dericks L; Gugger M; Galetta D; Spaggiari L; Schmid RA
    J Surg Oncol; 2010 Nov; 102(6):689-98. PubMed ID: 20721963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OCT4 expression in human uterine myometrial stem/progenitor cells.
    Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
    Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of transcriptional regulation of Oct4 (POU5F1) gene with distal enhancer].
    Nazarov IB; Krasnoborova VA; Mittenberg AG; Chikhirzhina EV; Davydov-Sinitsyn AP; Liskovykh MA; Tomilin AN
    Tsitologiia; 2013; 55(10):697-702. PubMed ID: 25509123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
    Soheili S; Asadi MH; Farsinejad A
    Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.